Related Experiment Video

Updated: Feb 26, 2026

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

54.8K

A case of liver abscess and fusobacterium septicemia

Elham Rahmati1, Rosemary C She2, Brittany Kazmierski3

  • 1Department of Medicine, Division of Infectious Diseases, Keck School of Medicine of the USC- LAC, United States.

Idcases
|July 25, 2017
PubMed

Insights

Fusobacterium nucleatum can cause a rare Lemierre's syndrome variant with intraabdominal infection and portal vein thrombosis. This case highlights hepatic abscess and septic pylephlebitis due to this pathogen.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Vascular Surgery

Background:

  • Fusobacterium species are known causes of Lemierre's syndrome, characterized by jugular vein thrombophlebitis.
  • A less common presentation involves invasive intraabdominal infection and portal vein thrombosis.

Purpose of the Study:

  • To describe a unique case of Fusobacterium nucleatum causing hepatic abscess and septic pylephlebitis.
  • To highlight an unusual variant of Lemierre's syndrome.

Main Methods:

  • Case report detailing clinical presentation, diagnostic findings, and management.
  • Microbiological identification of Fusobacterium nucleatum.

Main Results:

  • Successful identification of Fusobacterium nucleatum as the causative agent.
  • Demonstration of hepatic abscess and septic pylephlebitis.
  • Successful management of the patient.

Conclusions:

  • Fusobacterium nucleatum can present with severe intraabdominal infections, including hepatic abscess and septic pylephlebitis.
  • This presentation represents a unique variant of Lemierre's syndrome.
  • Early recognition and appropriate treatment are crucial for favorable outcomes.
Keywords:
16S rRNA sequencingFusobacteriumPortal vein thrombosisSeptic pylephlebitis

More Related Videos

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis03:42

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis

Published on: March 15, 2024

1.3K
Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos10:38

Deciphering and Imaging Pathogenesis and Cording of Mycobacterium abscessus in Zebrafish Embryos

Published on: September 9, 2015

11.1K

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
844
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
896